A Prospective Interventional Study to Evaluate the Effect of Hypoxia on Healthy Volunteers and Patients With Inflammatory Bowel Disease: The Altitude Inflammatory Bowel Disease Study

Inflammatory Bowel Disease

Comparing standard versus intensified pneumococcal vaccination regimens in patients with inflammatory bowel disease on biologics: a prospective, multicenter, randomized, open-label study

J Crohns Colitis

Roblin X, Vieujean S, Nancey S, Hebuterne X, Arab-Hocine N, Savoye G, Viennot S, Bouguen G, Fumery M, Duru G, Botelho-Nevers E, Berger AE, Tardy B, Mathieu N, Barrau M, Peyrin-Biroulet L, Paul S

doi: 10.1093/ecco-jcc/jjaf115

Inflammatory Bowel Disease

Deucravacitinib in Patients With Inflammatory Bowel Disease: 12-Week Efficacy and Safety Results From Three Randomized Phase 2 Studies in Crohn's Disease and Ulcerative Colitis

J Crohns Colitis

D'Haens G, Danese S, Panaccione R, Rubin DT, Peyrin-Biroulet L, Matsuoka K, Loftus EV Jr, Kobayashi T, Elsharkawi W, Miceli R, Ahmed S, Luo Y, Napoli A, Vaile J, Dornic Q, Patel A, Schreiber S

doi: 10.1093/ecco-jcc/jjaf080

Inflammatory Bowel Disease

A Real-World Longitudinal Case-Study Implementing Digital Screening and Treatment for Distress in Inflammatory Bowel Disease: The COMPASS-IBD Patient Journey

Inflamm Bowel Dis

Jones ASK, Seaton N, Harding S, Duff A, Hudson J, Wroe A, Norton S, Singh H, Onih J, Moss-Morris R

doi: 10.1093/ibd/izaf259

Inflammatory Bowel Disease

Increasing rate of hospitalization for inflammatory bowel disease is an age-related effect: A Canadian Population Study

Am J Gastroenterol

Goodwin SW, Wilk P, Yuan Y, Haan M, Jairath V

doi: 10.14309/ajg.0000000000003385

Inflammatory Bowel Disease

Treatment sequences, outcomes, healthcare utilization, and costs in patients with inflammatory bowel diseases requiring advanced treatment-real world comparative effectiveness from German claims data

BMC Gastroenterol

Dignass A, Teich N, Kaiser S, Sünwoldt J, Dünweber C, Weinhold I, Borchert J, Kudernatsch R

doi: 10.1186/s12876-025-04022-7

Inflammatory Bowel Disease

Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicentre retrospective cohort study

J Crohns Colitis

Noviello D, Chaparro M, Viganò C, Blesl A, Barberio B, Yanai H, Orlando A, Ferreiro-Iglesias R, Bezzio C, Zilli A, Molnár T, Gheorghe C, Conforti F, Innocenti T, Saibeni S, Bossuyt P, Oliveira R, Carvalhas Gabrielli AM, Losco A, Vieujean S, Tettoni E, Pirola L, Calderone S, Kornowski Cohen M, Dragoni G, Rath T, Barreiro-de Acosta M, Savarino EV, Gisbert JP, Vecchi M, Atreya R, Caprioli F

doi: 10.1093/ecco-jcc/jjaf056

Inflammatory Bowel Disease

Independent Predictors of 90-Day Readmission in Patients with Inflammatory Bowel Disease: A Nationwide Retrospective Study

J Crohns Colitis

Kunkle B, Singh H, Abraham D, Asamoah N, Barrow J, Mattar M

doi: 10.1093/ecco-jcc/jjaf034

Inflammatory Bowel Disease

Hidradenitis suppurativa among patients with new-onset inflammatory bowel disease - Results from the IBD Prognosis Study

J Crohns Colitis

Nielsen VW, Attauabi M, Holgersen N, Madsen GR, Bendtsen F, Seidelin J, Thomsen SF, Burisch J

doi: 10.1093/ecco-jcc/jjaf066

Hepatology

Effectiveness of a model of care based on Fibrosis-4 and liver stiffness measurement for the screening of patients with type 2 diabetes mellitus at risk of advanced liver disease: results from an Italian prospective multicentre study

Am J Gastroenterol

Caviglia GP, Ferro A, D'Ambrosio R, Perbellini R, Lampertico P, Periti G, Valenti L, Ciccioli C, Pennisi G, Petta S, Brodosi L, Petroni ML, Marchignoli F, Pironi L, Sagripanti A, Argenziano ME, Svegliati-Baroni G, Rosso C, Barutta F, Armandi A, Gruden G, Bugianesi E

doi: 10.14309/ajg.0000000000003493

Related content

Comparing standard versus intensified pneumococcal vaccination regimens in patients with inflammatory bowel disease on biologics: a prospective, multicenter, randomized, open-label study

Deucravacitinib in Patients With Inflammatory Bowel Disease: 12-Week Efficacy and Safety Results From Three Randomized Phase 2 Studies in Crohn's Disease and Ulcerative Colitis

A Real-World Longitudinal Case-Study Implementing Digital Screening and Treatment for Distress in Inflammatory Bowel Disease: The COMPASS-IBD Patient Journey

Increasing rate of hospitalization for inflammatory bowel disease is an age-related effect: A Canadian Population Study

Treatment sequences, outcomes, healthcare utilization, and costs in patients with inflammatory bowel diseases requiring advanced treatment-real world comparative effectiveness from German claims data

Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicentre retrospective cohort study

Independent Predictors of 90-Day Readmission in Patients with Inflammatory Bowel Disease: A Nationwide Retrospective Study

Hidradenitis suppurativa among patients with new-onset inflammatory bowel disease - Results from the IBD Prognosis Study

Effectiveness of a model of care based on Fibrosis-4 and liver stiffness measurement for the screening of patients with type 2 diabetes mellitus at risk of advanced liver disease: results from an Italian prospective multicentre study